Firstwordpharma

Published October 13, 2026 · Updated October 14, 2026

Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore ...

Read the full story at Firstwordpharma

Psychedelic -Inspired Compounds for Cognitive Impairment and Neurodegeneration. Press Release . By: Ref: PR Newswire. Published: 10/13/2026. Jocasta.